YU39617B - Process for obtaining a new vincamin derivative - Google Patents

Process for obtaining a new vincamin derivative

Info

Publication number
YU39617B
YU39617B YU845/77A YU84577A YU39617B YU 39617 B YU39617 B YU 39617B YU 845/77 A YU845/77 A YU 845/77A YU 84577 A YU84577 A YU 84577A YU 39617 B YU39617 B YU 39617B
Authority
YU
Yugoslavia
Prior art keywords
vincamin
derivative
obtaining
new
vincamin derivative
Prior art date
Application number
YU845/77A
Other versions
YU84577A (en
Inventor
C Ferrer
J Colome
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of YU84577A publication Critical patent/YU84577A/en
Publication of YU39617B publication Critical patent/YU39617B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YU845/77A 1976-03-31 1977-03-30 Process for obtaining a new vincamin derivative YU39617B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES446755A ES446755A1 (en) 1976-03-31 1976-03-31 Vincamine salt and a process for its production

Publications (2)

Publication Number Publication Date
YU84577A YU84577A (en) 1982-08-31
YU39617B true YU39617B (en) 1985-03-20

Family

ID=8471315

Family Applications (1)

Application Number Title Priority Date Filing Date
YU845/77A YU39617B (en) 1976-03-31 1977-03-30 Process for obtaining a new vincamin derivative

Country Status (11)

Country Link
JP (1) JPS52143215A (en)
AT (1) AT352302B (en)
BE (1) BE853136A (en)
CH (1) CH601322A5 (en)
DE (1) DE2714486A1 (en)
ES (1) ES446755A1 (en)
FR (1) FR2346008A1 (en)
GB (1) GB1545012A (en)
NL (1) NL7703550A (en)
YU (1) YU39617B (en)
ZA (1) ZA771977B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58147394U (en) * 1982-03-27 1983-10-04 オンキヨー株式会社 speaker
JPS6395390U (en) * 1986-12-09 1988-06-20

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2274283A1 (en) * 1974-06-12 1976-01-09 Castaigne Sa Vincamine 2-(para hydroxy benzoyl) benzoate - vasodilator and cerebral oxygenator-from salts of vincamine and the substd benzoic acid
ES430059A1 (en) * 1974-09-14 1976-10-16 Roger Lab Process for preparing vincamine nicotinate salt

Also Published As

Publication number Publication date
NL7703550A (en) 1977-10-04
CH601322A5 (en) 1978-07-14
ES446755A1 (en) 1977-06-01
BE853136A (en) 1977-07-18
ZA771977B (en) 1978-03-29
DE2714486A1 (en) 1977-10-06
JPS5751395B2 (en) 1982-11-01
ATA221577A (en) 1979-02-15
GB1545012A (en) 1979-05-02
AT352302B (en) 1979-09-10
FR2346008B1 (en) 1985-02-15
YU84577A (en) 1982-08-31
JPS52143215A (en) 1977-11-29
FR2346008A1 (en) 1977-10-28

Similar Documents

Publication Publication Date Title
EG13530A (en) A process for preparing imidazolderivates
YU321180A (en) Process for obtaining a 2-amino-4-hydroxy-quinazoline derivative
YU40820B (en) Process for obtaining phenoxy-amino-propanes
YU39981B (en) Process for obtaining n-phosphono-methylglycine
YU306977A (en) Process for obtaining dimethylther
YU28877A (en) Process for obtaining meta-aryloxybenzaldehyde
YU39808B (en) Process for obtaining polysaccharides
YU42613B (en) Process for obtaining 4-halo-gendihydropyrans
YU40306B (en) Process for obtaining sitosterole-beta-d-glucoside
YU143177A (en) Process for obtaining sulfinyl-chloride
YU171677A (en) Process for obtaining 5-m-tolyloxyuracyl
PT66984A (en) Process for preparing a dimeric indole-dihydroindolecarboxamide
YU162577A (en) Process for obtaining guaiacol-p-isobutyl-hydrotropate
PT67343B (en) Process for preparing a spirooxazolidinedione
YU40667B (en) Process for obtaining alpha-cyano-3-phenoxycenzyl-carboxylates
PH15353A (en) A process for 2-chlorosulfinylazetidin-4-ones
YU40314B (en) Process for obtaining thymosine
YU39617B (en) Process for obtaining a new vincamin derivative
YU240682A (en) Process for obtaining a new 2-methyl-2-cyanmethyl-5-isopropyl-tetrahydrofurane
IL54521A0 (en) A process for preparing thiopheols
GB2001651B (en) Process for producing a rush-like structure
YU214877A (en) Process for obtaining transformer-oil
YU314277A (en) Process for obtaining haloacylamides
YU39994B (en) Process for obtaining chloro-4-alkoxycarbonyl-5-methoxy-2-pyrimidines
YU257577A (en) Process for obtaining trans-5a-aryl-decahydro-1h-2-and-1h-3-benzazepine